All News

The study evaluated whether conditions such as depression in adolescence are associated with a higher risk of cardiovascular disease in adulthood.

In a viewpoint article published in JAMA, researchers proposed reforms that could improve the authorization and approval process during public health crises to increase the public’s trust in the agency.

Azacitidine showed an overall survival benefit among patients with acute myeloid leukemia compared with a placebo.

The development of the COVID-19 vaccine AZD1222 has expanded into a phase 3 trial that is enrolling 30,000 adults aged 18 years or older to assess its safety, efficacy, and immunogenicity.

Oral chemotherapy may be an important option for patients during the COVID-19 pandemic, as it would allow them to receive treatment at home.

An analysis of phase 3 study data found that 99% of patients who received inclisiran showed a significant placebo-adjusted reduction in low-density lipoprotein cholesterol (LDL-C).

From navigating online classes to adjusting to either cancelled or switched experiential learning rotations, the pandemic has changed the lives of pharmacy students worldwide.

Athletes and endurance athletes are at an increased risk of atrial fibrillation.

Contrary to previous studies, the rate of cognitive impairment has increased over the past 20 years.

A study linked cognitive impariment to worse prognoses in a larger group of heart failure patients.

Women who typically have a better prognosis in the primary breast cancer setting experienced worse survival after a second primary breast cancer.

Evolocumab in combination with statins and other lipid-lowering therapies was found to significantly reduce low-density lipoprotein cholesterol in pediatric patients with heterozygous familial hypercholesterolemia.

Despite improvements in the understanding and treatment of chemotherapy-induced nausea and vomiting (CINV), nausea and emesis continue to be a distressing adverse event for patients.

The effect of bacteria in the intestines on myelin and the brain may worsen the symptoms of multiple sclerosis.

Millions of Americans have vision impairments and ensuring their access to websites is not only important for their health but is also a good business practice.

Investigators found that approximately 36% of the patients studied received a dosage strength of 250 mg of morphine over a 5-day period, above the CDC’s threshold for risky opioid prescribing.

New research contradicts previous observational studies on the effect of vitamin D supplements in severe asthma prevention.

A patient is experiencing severe brain fog, difficulty speaking, bilateral muscle weakness, and ataxia.

Pharmacy Times spoke with Mark Calarco, MD, National Medical Director for Clinical Diagnostics, American Addiction Centers, about International Overdose Awareness Day.

Top news of the week from Pharmacy Times®.

The cysteamine ophthalmic solution drops are applied 4 times a day.

A new medication for certain rare blood cancers has now become available through a limited distribution with AllianceRx Walgreens Prime.

The National Association of Chain Drug Stores (NACDS) has urged governors and state executive teams to take actions to support vaccine access for patients from their local pharmacies.

Although a study suggests that patients may show a clinical improvement when receiving a 5-day course of remdesivir, investigators said this is of uncertain clinical significance.

Metabolic studies have found that although pregnancy reduces the body’s sensitivity to insulin, lactation may restore it.

The new studies found that for some patients, the use of steroid medications to reduce inflammation slighly increased the likelihood of needing hospital care for COVID-19.

Researchers at the University of Alabama in Tuscaloosa observed a statistically significant correlation between the occurrence of obesity and negative outcomes from COVID-19.

The American Society of Health-System Pharmacists has issued a list of best practices to ensure an equitable distribution of the vaccine.